Effects of acute liver injury on blood coagulation
暂无分享,去创建一个
D. Stirling | P. Newsome | C. Ludlam | E. Thomson | P. Dawson | R. Kerr | L. Germain | Ron Kerr
[1] R. Cardigan,et al. The effect of leucocyte depletion on the quality of fresh‐frozen plasma , 2001, British journal of haematology.
[2] M. Shima,et al. Cell Surface Heparan Sulfate Proteoglycans Participate in Factor VIII Catabolism Mediated by Low Density Lipoprotein Receptor-related Protein* , 2001, The Journal of Biological Chemistry.
[3] A. Chuansumrit,et al. Combined Fresh Frozen Plasma with Recombinant Factor VIIa in Restoring Hemostasis for Invasive Procedures in Children with Liver Diseases , 2001, Thrombosis and Haemostasis.
[4] A. Burroughs,et al. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? , 1999, American Journal of Gastroenterology.
[5] A. Burroughs,et al. Original ContributionsDisseminated intravascular coagulation in liver cirrhosis: fact or fiction? , 1999 .
[6] K. Simpson. Cytokines, for better or worse? , 1999, European journal of gastroenterology & hepatology.
[7] E. Waller,et al. Expression of Factor VIII by Murine Liver Sinusoidal Endothelial Cells* , 1999, The Journal of Biological Chemistry.
[8] M. Sallese,et al. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis , 1998, Gut.
[9] F. Neumann,et al. Effect of human recombinant interleukin-6 and interleukin-8 on monocyte procoagulant activity. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Williams,et al. The management of abnormalities of hemostasis in acute liver failure. , 1996, Seminars in liver disease.
[11] R. Wilson,et al. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. , 1995, Toxicology and applied pharmacology.
[12] N. Mackman,et al. Transcriptional regulation of tissue factor expression in human endothelial cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[13] A. Thomson,et al. Circulating proinflammatory cytokines (IL‐1β, TNF‐α, and IL‐6) and IL‐1 receptor antagonist (IL‐1Ra) in fulminant hepatic failure and acute hepatitis , 1994 .
[14] A. Forbes,et al. Thrombin—antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome , 1990, European journal of clinical investigation.
[15] P. Tracy,et al. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. , 1990, The Journal of biological chemistry.
[16] D D Monkovic,et al. Activation of human factor V by factor Xa and thrombin. , 1990, Biochemistry.
[17] R Williams,et al. Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.
[18] W. Fiers,et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[19] Roger Williams,et al. Increased Factor VIII Complex in Fulminant Hepatic Failure , 1985, Thrombosis and Haemostasis.
[20] B. Osterud,et al. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[21] B. Gazzard,et al. The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. , 1975, Gut.
[22] B. Gazzard,et al. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. , 1975, Gut.
[23] L. Poller,et al. Coagulation Studies as a Prognostic Index in Acute Liver Failure , 1975, British journal of haematology.
[24] B. Gazzard,et al. A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis , 1974, Gut.
[25] A. Clauss,et al. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens , 1957 .
[26] D. Stirling,et al. Transcriptional Activation of the Factor VIII Gene in Liver Cell Lines by Interleukin-6 , 1998, Thrombosis and Haemostasis.
[27] J. Freedman,et al. Control Mechanisms in Thrombin Generation , 1996, Seminars in thrombosis and hemostasis.
[28] A. Thomson,et al. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. , 1994, Clinical and experimental immunology.
[29] A. Forbes,et al. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. , 1993, Journal of hepatology.
[30] F. Duckert. Behaviour of antithrombin 3 in liver disease. , 1973, Scandinavian journal of gastroenterology. Supplement.
[31] P. Straub. Intravascular coagulation in acute hepatic necrosis. , 1970, Lancet.